Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes

• Status: Completed
• Trial end date: 2002-11-20
• Target enrollment: 0
• Participant gender: All

Summary

This trial is conducted in Europe. The aim of this trial is to compare the pharmacokinetic profile of two different methods of insulin administration in children with type 1 diabetes.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Type 1 diabetes

• Treatment for at least 12 months

• HbA1c lesser or equal to 11.0%

• Body weight between 25 and 80 Kg

• Capable to use the device

Exclusion Criteria:

• Any diseases other than diabetes requiring prescriptive medication

• Known or suspected allergy to trial product or related products

• Active proliferative retinopathy as judged by the Investigator

• Recurrent severe hypoglycaemia as judged by the Investigator

• The receipt of any investigational drug within 4 weeks prior to this trial